| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,214 |
12,408 |
$661K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,168 |
3,535 |
$188K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,971 |
5,308 |
$141K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,727 |
2,444 |
$91K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,430 |
1,331 |
$67K |
| 87631 |
|
1,049 |
951 |
$64K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,283 |
11,696 |
$56K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,655 |
3,258 |
$49K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,405 |
4,896 |
$43K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,694 |
2,854 |
$43K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,754 |
1,487 |
$38K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,732 |
4,171 |
$37K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
506 |
470 |
$36K |
| 99051 |
|
1,786 |
1,640 |
$22K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
642 |
605 |
$20K |
| 87486 |
|
1,152 |
1,037 |
$16K |
| 87581 |
|
1,152 |
1,037 |
$16K |
| 86328 |
|
308 |
208 |
$9K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,129 |
1,021 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
5,164 |
4,659 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
144 |
139 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,597 |
2,339 |
$2K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
37 |
34 |
$1K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
297 |
280 |
$928.81 |
| 81003 |
|
626 |
596 |
$721.73 |
| 87807 |
|
70 |
68 |
$634.55 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,770 |
2,492 |
$400.16 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
37 |
34 |
$339.28 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
169 |
143 |
$259.18 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
142 |
117 |
$128.82 |
| 90686 |
|
39 |
36 |
$98.06 |
| 82150 |
|
33 |
32 |
$70.51 |
| 82977 |
|
33 |
32 |
$44.05 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
154 |
120 |
$35.82 |
| 84550 |
|
33 |
32 |
$34.76 |
| 84460 |
|
33 |
32 |
$24.33 |
| 84450 |
|
33 |
32 |
$23.77 |
| 84075 |
|
33 |
32 |
$23.77 |
| 82247 |
|
33 |
32 |
$23.05 |
| 82040 |
|
33 |
32 |
$22.75 |
| 82947 |
|
46 |
45 |
$21.24 |
| 84155 |
|
33 |
32 |
$16.83 |
| 36416 |
|
3,831 |
3,430 |
$14.00 |
| 82310 |
|
33 |
32 |
$13.92 |
| 82565 |
|
33 |
32 |
$13.83 |
| 84520 |
|
33 |
32 |
$10.68 |
| J0945 |
Injection, brompheniramine maleate, per 10 mg |
46 |
36 |
$0.00 |
| 80051 |
|
17 |
17 |
$0.00 |